Author:
Suk Yujin,Singh Sheila K.
Subject
General Biochemistry, Genetics and Molecular Biology
Reference10 articles.
1. Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results;Goldsmith;Nat. Med.,2023
2. Matthay KK, Maris JM, Schleiermacher G, Nakagawara A, Mackall CL, Diller L, , Weiss W.A., Nat. Rev. Dis. Primers 2016, 2, 16078.
3. Neuroblastoma-A neural crest Derived Embryonal Malignancy;Johnsen;Front. Mol. Neurosci.,2019
4. Advancing therapy for neuroblastoma;Qiu;Nat. Rev. Clin. Oncol.,2022
5. ALK in neuroblastoma: Biological and therapeutic implications;Trigg;Cancers,2018